Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

<< Previous

Bullboard Posts

Next >>

Post by steadfaston Jun 15, 2021 3:03pm

174 Views

Post# 33389744

Dr Piotr Witkowski Facebook March 16, 2021

One of our patients received islet transplantation right before the outbreak of the pandemic
last year. Now she is celebrating anniversary of her freedom from insulin. We resumed our
study in the islet transplantation in the fall of last year.

There is a photo of Dr Witkowski, with a lady, likely the one he described as Celebrating
with a younger lady. Could be Mother/Daughter or Sisters.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing